000			02013 a2200553 4500
005			20250515031117.0
264		0	_c20061204
008			200612s 0 0 eng d
022			_a1478-3223
024	7		_a10.1111/j.1478-3231.2006.01263.x _2doi
040			_aNLM _beng _cNLM
100	1		_aFujiwara, Keiichi
245	0	0	_aTwenty-four weeks of interferon alpha-2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1. _h[electronic resource]
260			_bLiver international : official journal of the International Association for the Study of the Liver _cJun 2006
300			_a520-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aJapan
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aRNA, Viral _xblood
650	0	4	_aRecombinant Proteins
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aYokosuka, Osamu
700	1		_aKomine, Fumihiko
700	1		_aMoriyama, Mitsuhiko
700	1		_aKato, Naoya
700	1		_aYoshida, Haruhiko
700	1		_aTanaka, Naohide
700	1		_aImazeki, Fumio
700	1		_aShiratori, Yasushi
700	1		_aArakawa, Yasuyuki
700	1		_aOmata, Masao
773	0		_tLiver international : official journal of the International Association for the Study of the Liver _gvol. 26 _gno. 5 _gp. 520-8
856	4	0	_uhttps://doi.org/10.1111/j.1478-3231.2006.01263.x _zAvailable from publisher's website
999			_c16357798 _d16357798